Minervax AB
559235-0085ActiveDeveloping a life-saving prophylactic vaccine against Group B Streptococcus.
Yleiskatsaus
- 20–49
- Työntekijät
- 50–100milj SEK
- Liikevaihto
- 2020
- Perustettu
Avainpäättäjät
Per Fischer
CEO
Bengt Johansson Lindbom
CSO
Christopher Gagliardi
Board member
Tal Zaks
Board member
+22 lisää yhteystietoja Funnelfeedrissä
Kuvaus
MinervaX is a clinical-stage biotechnology company dedicated to making a significant global impact through medical innovation. The organization focuses specifically on developing a state-of-the-art prophylactic vaccine targeting Group B Streptococcus (GBS). Their primary motivation is to prevent adv...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Bioteknisk forskning och utveckling
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE559235008501
Päättäjät
26 yhteystietoa FunnelfeedrissäPer Fischer
CEO
Bengt Johansson Lindbom
CSO
Christopher Gagliardi
Board member
Tal Zaks
Board member
Bjørn Kantsø
CTO, Head of CMC
Varun Gupta
Board member
Bita Sehat
Board member
Jean Smal
Advisory Board Member
Xavier Sáez Llorens
Advisory Board Member
Kabeer Aziz
Board member
Michael Pfleiderer
Advisory Board Member
Ralf Clemens
Advisory Board Member
Patrik Sobocki
Board member
Inca Kusters
Advisory Board Member
Vincent Brichard
Board member
Geert Leroux-Roels
Advisory Board Member
Clement Lewin
Advisory Board Member
Jean-Paul Prieels
Advisory Board Member
Emmanuelle Coutanceau
Board member
Veronica Gambillara Fonck
Chair of the Board
Sten Verland
Board member
Lidia Oostvogels
CMO
Heinz-Josef (Joe) Schmitt
Advisory Board Member
William Ripley Ballou
Advisory Board Member
Peter A. Patriarca
Advisory Board Member
Terri Genthe
Chief Regulatory and Quality Officer
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäBavarian Nordic Sweden AB
1–4 työntekijätPioneering global developer and manufacturer of life-saving vaccines.
Biogaia New Sciences AB
1–4 työntekijätLeading Swedish company developing scientifically validated probiotic products globally.
ZalVac AB
1–4 työntekijätZalVac develops robust vaccines against various bacterial strains.
BioGaia Pharma AB
0 työntekijätDeveloping and out-licensing novel biotherapeutic platforms from microbiome research.
ImmuneBiotech Medical Sweden AB
Pioneering precision probiotics for gastrointestinal and neurological health.
Selaa lisää
Kysymyksiä yrityksestä Minervax AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo